Company intelligence / Profile preview

NLT SPINE

Ownership
Private
Employees
~2
Development stage
Commercial
01

Overview

NLT SPINE has developed a suite of minimally invasive spine surgery devices based on its patented non-linear technology. Its flagship PROW FUSION™ expandable TLIF cage and eSPIN™ discectomy tool are FDA-cleared and have shown positive initial clinical results. The company’s portfolio also includes wearable neurostimulation devices for post-op recovery and home care solutions such as smart braces and PEMF therapy rings.

Therapeutic areas
OtherRheumatologyNeurology
Modalities
DeviceWearable deviceNon-pharmacological therapy
Industry
Surgical Medical Devices
02

Partnerships

Collaborations with leading academic centers

Beyond the preview

Go deeper on NLT SPINE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLT SPINE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call